Category: Pericarditis

The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients—A Large Population-Based Study

Posted on | Posted on John Murphy | Leave a Comment on The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients—A Large Population-Based Study

Authors: Ortal Tuvali 1,†,Sagi Tshori 2,†,Estela Derazne 3,et. al. Abstract Myocarditis and pericarditis are potential post-acute cardiac sequelae of COVID-19 infection, arising from adaptive immune responses. We aimed to study the incidence of post-acute COVID-19 myocarditis and pericarditis. Retrospective cohort study of 196,992 adults after COVID-19 infection in Clalit Health Services members in Israel between March 2020 and […]

COVID-19 Presenting as Encephalitis and Myopericarditis: A Report of a Rare Case

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 Presenting as Encephalitis and Myopericarditis: A Report of a Rare Case

Nikolaos Kakaletsis • Ioannis Alevroudis • Serafeim-Chrysovalantis Kotoulas •et. al., Published: June 10, 2024, DOI: 10.7759/cureus.62056  Abstract COVID-19 might present with a wide range of clinical manifestations, from mild respiratory distress to severe multi-organ dysfunction. We present a unique case of complex COVID-19 presentation in a 45-year-old female who initially developed general symptoms such as fever, cough, headache, and weakness, which escalated […]

Oxford University: Myocarditis and Pericarditis Only Appear After COVID Vaccination, Not After COVID Infection

Posted on | Posted on John Murphy | Leave a Comment on Oxford University: Myocarditis and Pericarditis Only Appear After COVID Vaccination, Not After COVID Infection

By Margaret Flavin Jun. 2, 2024 Epoch Times Researchers at Oxford University evaluated over one million English children aged 5 to 11 and adolescents aged 12 to 15 for incidents of myocarditis and pericarditis in relation to the COVID-19 infection and the COVID-19 vaccine. According to the preprint, myocarditis and pericarditis only occur after vaccination and not […]

Lung Damage & Shortness of Breath After the COVID-19 Vaccine

Posted on | Posted on John Murphy | Leave a Comment on Lung Damage & Shortness of Breath After the COVID-19 Vaccine

September 18, 2023 The COVID Long-haul Foundation: Opinion Shortness of breath is a side effect of the COVID-19 vaccine that has been found in vaccinated individuals. It can be caused by a few different things, including: Myocarditis and Pericarditis After the COVID-19 Vaccine Myocarditis and pericarditis are two types of heart inflammation that can occur […]

Latest survey shows the COVID vaccines are a disaster: ~750,000 dead in US

Posted on | Posted on John Murphy | Leave a Comment on Latest survey shows the COVID vaccines are a disaster: ~750,000 dead in US

In US, ~5M people who got the vaccine are now unable to work and ~750,000 are dead. The rate of heart issues is 6.6%, far more than they claimed. No wonder our government isn’t doing these surveys! Authors: Steve Kirsch Jun 25, 2022 “With over 40 years of experience in genomics, bioinformatics and development of […]

New Study Contradicts ‘Experts’ – Shows Unvaccinated Adults Found “No increase in Myocarditis and Pericarditis” Following COVID Infection

Posted on | Posted on John Murphy | Leave a Comment on New Study Contradicts ‘Experts’ – Shows Unvaccinated Adults Found “No increase in Myocarditis and Pericarditis” Following COVID Infection

Authors:  Jim Hoft July 8, 2022 Gateway Pundit A new study from Israel reveals that there was “no increase in the incidence of myocarditis and pericarditis” in unvaccinated adults who had COVID-19 infection. This contradicts the findings of earlier studies that suggested there may be a connection between cardiac inflammation and coronavirus infections. In a […]

Vaccinated Up to 15X MORE LIKELY Than Unvaxxed to Develop Heart Inflammation Requiring Hospitalization: Peer Reviewed Study

Posted on | Posted on John Murphy | Leave a Comment on Vaccinated Up to 15X MORE LIKELY Than Unvaxxed to Develop Heart Inflammation Requiring Hospitalization: Peer Reviewed Study

Authors:  Julian Conradson Published April 25, 2022 at 4:14pm A new study out of Europe has revealed that cases of heart inflammation that required hospitalization were much more common among vaccinated individuals compared to the unvaccinated. A team of researchers from health agencies in Finland, Denmark, Sweden, and Norway found that rates of myocarditis and pericarditis, two forms of […]

SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis

Posted on | Posted on John Murphy | Leave a Comment on SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis

Authors: RALPH TURCHIANO   SEPTEMBER 8, 2021 •  Abstract Establishing the rate of post-vaccination cardiac myocarditis in the 12-15 and 16-17-year-old population in the context of their COVID-19 hospitalization risk is critical for developing a vaccination recommendation framework that balances harms with benefits for this patient demographic. Design, Setting and Participants: Using the Vaccine Adverse Event Reporting […]

Colchicine: A Possible COVID-19 Long haul Cardiac Therapy

Posted on | Posted on John Murphy | Leave a Comment on Colchicine: A Possible COVID-19 Long haul Cardiac Therapy

Last Updated: December 16, 2021 Last Updated: December 16, 2021 Colchicine is an anti-inflammatory drug that is used to treat a variety of conditions, including gout, recurrent pericarditis, and familial Mediterranean fever.1 Recently, the drug has been shown to potentially reduce the risk of cardiovascular events in those with coronary artery disease.2 Colchicine has several potential mechanisms of action, […]

The Role of Colchicine in Pericardial Syndromes

Posted on | Posted on John Murphy | Leave a Comment on The Role of Colchicine in Pericardial Syndromes

Authors: George Lazaros 1, Massimo Imazio 2, Antonio Brucato 3, Charalambos Vlachopoulos 1, Emilia Lazarou 1, Dimitrios Vassilopoulos 4, Dimitris Tousoulis 1PMID: 29336245 DOI: 10.2174/1381612824666180116101823 Curr Pharm Des . 2018;24(6):702-709. doi: 10.2174/1381612824666180116101823. Abstract Background: Colchicine is an old drug originally employed for the treatment of inflammatory disorders such as acute gout and familiar Mediterranean fever. Methods: In the past few decades, colchicine has been at the forefront of the pharmacotherapy of several […]